Company / Depreciation & Amortization
Yubo International Biotech Ltd Depreciation & Amortization History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$167.6K
FY2025
5-year range
$13.1K / $178.3K
FY2021-FY2025
Trend
-1.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $178,312 to $167,581 over the past 2 years.
Based on SEC 10-K filings.
$167,581 in FY2025 with a 5-year CAGR of +66.6%.
Improved from $178,312 to $167,581 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +110.0%
- 5-Year CAGR
- +66.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +66.6%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 1.4% year-over-year.
- Peak depreciation & amortization was recorded in FY2023.
- Lowest depreciation & amortization in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $167.6K | -1.4% |
| FY2024 | $169.9K | -4.7% |
| FY2023 | $178.3K | +885.3% |
| FY2022 | $18.1K | +38.5% |
| FY2020 | $13.1K | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026